Discovery of Novel Aminobutanoic Acid-Based ASCT2 Inhibitors for the Treatment of Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Discovery of Novel Aminobutanoic Acid-Based ASCT2 Inhibitors for the Treatment of Non-Small-Cell Lung Cancer

Published:2024-01-13 Issue:2 Volume:67 Page:988-1007
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Qin Lian¹,Cheng Xinying¹,Wang Shijiao²,Gong Guangyue¹,Su Huiyan¹,Huang Huidan³,Chen Tian¹,Damdinjav Davaadagva⁴,Dorjsuren Buyankhishig⁵,Li Zhiyu¹^ORCID,Qiu Zhixia²,Bian Jinlei¹^ORCID

Affiliation:

1. State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 211100, P. R. China

2. Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing 211100, P. R. China

3. School of Pharmacy, Wannan Medical College, Wuhu 241002, P. R. China

4. School of Pharmacy, Mongolian National University of Medical Science, Ulaanbaatar 14210, Mongolia

5. Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, P. R. China

Funder

Qinglan Project of Jiangsu Province of China

National Natural Science Foundation of China

Outstanding Youth Foundation of Jiangsu Province

Funding of Double First-Rate Discipline Innovation Team

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c01093

Reference39 articles.

1. The Effect of Advances in Lung-Cancer Treatment on Population Mortality

2. Definitive and Adjuvant Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline

3. Perspectives on Treatment Advances for Stage III Locally Advanced Unresectable Non-Small-Cell Lung Cancer

4. Restricting Glutamine Uptake Enhances NSCLC Sensitivity to Third-Generation EGFR-TKI Almonertinib

5. Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism of Protopanaxadiol Triphenylphosphate Derivative in Non-Small-Cell Lung Cancer;Molecules;2024-09-09

2. Glutaminolysis is a Potential Therapeutic Target for Kidney Diseases;Diabetes, Metabolic Syndrome and Obesity;2024-07